Mi SciELO
Servicios Personalizados
Revista
Articulo
Indicadores
- Citado por SciELO
- Accesos
Links relacionados
- Citado por Google
- Similares en SciELO
- Similares en Google
Compartir
Oncología (Barcelona)
versión impresa ISSN 0378-4835
Resumen
GUTIERREZ ABAD, D.; CASADO HERRAEZ, A.; FILIPOVICH VEGAS, E. y HERNANDEZ MURO, G.. Efficacy of the first-line treatment with capecitabin monotherapy of patients with vagina epidermoid carcinoma and lung metastases, in terms of clinical response according to the RECIST criteria. Oncología (Barc.) [online]. 2006, vol.29, n.10, pp.37-39. ISSN 0378-4835.
Literature data about chemotherapy of vaginal metastatic squamous cell carcinoma are limited because of the rare incidence of this kind of tumours. In addition, some patients evaluated in clinical practice, usually are not good candidates for standard treatments or clinical trials. This situation makes new treatments a good choice, unless patients meet the selection criteria to be included in a clinical trial. We present a case of lung metastatic vaginal carcinoma with partial response (RECIST criteria) after three cycles of capecitabine monotherapy.
Palabras clave : Squamous cell vaginal carcinoma; Lung metastases; Capecitabine.